Engaging Moms on Teen Indoor Tanning Through Social Media

NCT02835807 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1607

Last updated 2022-10-20

No results posted yet for this study

Summary

A sample of mothers in Tennessee are recruited to a group-randomized pretest-posttest controlled trial evaluating the effect of a social media campaign to decrease mothers' permissiveness for daughters to indoor tan. The primary outcomes is mothers' permissiveness for indoor tanning by daughters. Secondary outcomes are mother's indoor tanning prevalence and their support for stricter bans on indoor tanning by minors.

Conditions

Interventions

BEHAVIORAL

Health Chat including Indoor Tanning

Participants in the intervention join a private Facebook group to participate in the Health Chat program. The group is not viewable to the public, including other Facebook users. The content of Health Chat is designed primarily for mothers, the participants in the group. Posts will occur twice daily for 12 months for a total of 720 posts. Each group will be hosted by a moderator who is responsible for managing the intervention goals and mothers' engagement. Mothers likely will not continuously engage with a social media campaign that is limited only to indoor tanning. To engage mothers in the Health Chat program, content addressing several major health and wellness topics relevant to adolescent girls and their mothers will be posted.

BEHAVIORAL

Health Chat excluding Indoor Tanning

In the comparison condition, 25% of the posts will be about prescription drug abuse and misuse. Prescription drug abuse was selected as control content because it is a) completely unrelated to tanning, and b) an emerging issue of great interest and relevance to young adults in east Tennessee. This 25% segment of posts is the only difference between the intervention and comparison conditions.

Sponsors & Collaborators

  • East Tennessee State University

    collaborator OTHER
  • Colorado State University

    collaborator OTHER
  • University of Connecticut

    collaborator OTHER
  • National Cancer Institute (NCI)

    collaborator NIH
  • Klein Buendel, Inc.

    lead INDUSTRY

Principal Investigators

  • David Buller, PhD · Klein Buendel, Inc.

  • Sherry Pagoto, PhD · University of Connecticut

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2022-05-31
Completion
2022-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02835807 on ClinicalTrials.gov